Revamp Medical

Series-A
revampmedical.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Series-A
Last Announced May 30, 2023
Investors Undisclosed
Decision Makers 5 Available

About Revamp Medical

A manageable, flow-reducing central venous device designed to enhance the efficacy of diuretic therapy while preserving renal function.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website revampmedical.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised undisclosed · Series-A

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Revamp Medical.

Funding History

1 Round
Series-A equity · May 30, 2023

Founders & Leadership

1

Lihu Avitov

CO-FOUNDER, CFO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts